Butyl and butynyl benzyl amine compounds

Details for Australian Patent Application No. 2007265239 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Letavic, Michael A.; Keith, John M.; Stocking, Emily M.

Agent Shelston IP

Pub. Number AU-A-2007265239

PCT Pub. Number WO2008/002817

Priority 60/806,165 29.06.06 US

Filing date 21 June 2007

Wipo publication date 3 January 2008

International Classifications

C07C 217/62 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07C 321/28 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides

C07D 211/38 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/65 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/002817 Priority application(s): WO2008/002817

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007265240-Substituted aminomethyl benzamide compounds

2007265238-Substituted benzamide modulators of the histamine H3 receptor